These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Anaphylactic reaction to galactose-derived oligosaccharide residues from lactose used as a drug excipient. Andrade ALMB; Riccetto AGL; Vilela MMDS; de Oliveira DN; Catharino RR; Nolasco da Silva MT Pediatr Allergy Immunol; 2018 Mar; 29(2):207-210. PubMed ID: 29197126 [No Abstract] [Full Text] [Related]
47. Severe Polyethylene Glycol Allergy Considerations for Perioperative Management: A Case Report. Wong-On-Wing A; Ruth K; Hinerth K; Deng A; Woldekiros M; Ellenbogen RG; Crowder CM A A Pract; 2022 Oct; 16(10):e01619. PubMed ID: 36219725 [TBL] [Abstract][Full Text] [Related]
48. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study. Saito J; Nakamura H; Akabane M; Yamatani A Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination. Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of hydroperoxides in common pharmaceutical excipients. Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844 [TBL] [Abstract][Full Text] [Related]
51. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review. Patel R; Barker J; ElShaer A Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153099 [TBL] [Abstract][Full Text] [Related]
53. Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations. Thomazini VC; da Cunha GM; Guimarães NM; Saleme SD; de Melo RCG; de Paula GA; Carvalho SG; Chorilli M; Dos Santos Giuberti C; Villanova JCO Daru; 2024 Jun; 32(1):289-305. PubMed ID: 37903944 [TBL] [Abstract][Full Text] [Related]
55. Place of excipients in systemic drug allergy. Barbaud A Immunol Allergy Clin North Am; 2014 Aug; 34(3):671-9, x. PubMed ID: 25017684 [TBL] [Abstract][Full Text] [Related]
56. Inconsistent excipient listings in DailyMed: implications for drug safety. Kinsella L; Brook J; Briest M; Brook MJ Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38563879 [TBL] [Abstract][Full Text] [Related]
57. Pharmaceutical excipient development: the need for preclinical guidance. Baldrick P Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777 [TBL] [Abstract][Full Text] [Related]
58. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan. Chang LC; Kang JJ; Gau CS Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930 [TBL] [Abstract][Full Text] [Related]
59. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas. Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480 [TBL] [Abstract][Full Text] [Related]
60. Harmful excipients in medicines for neonates in Spain. Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]